4717539 Corrosion resistant alloys

4717539 Corrosion resistant alloys

PATENT ABSTRACTS triphenylmethyl derivatives of sn-glycero-3phosphocholine and sn-glycero-3o phosphoethanolamine. 281 4717565 PROCESS FOR THE PREPAR...

53KB Sizes 3 Downloads 107 Views

PATENT ABSTRACTS triphenylmethyl derivatives of sn-glycero-3phosphocholine and sn-glycero-3o phosphoethanolamine.

281 4717565

PROCESS FOR THE PREPARATION OF MEDICAMENT ADSORBATES John Denick assigned to Warner-Lambert Company

4717539 CORROSION RESISTANT ALLOYS David P Morisey assigned to Phillips Alma; Finley Hugh A group of alloys exhibiting good corrosion resistance and with properties suitable for fabricating dental prostheses consist essentially of copper, nickel and tantalum. Copper and nickel comprise the major components, while tantalum is present in lesser quantities. Lithium and/or Ce, Si metal may be added in small amounts as a deoxidant. Minor amounts of elements such as aluminum, gallium, indium, silicon, titanium and cerium can be added to modify the physical properties of the alloys.

4717563 2-ALKOXY-N-(1AZABICYCLO(2.2.2)OCT-3-YL) BENZAMIDES AND THIOBENZAMIDES IN A METHOD FOR ALLEVIATING EMESIS CAUSED BY NONPLATINUM ANTICANCER DRUGS Reevis S Alphin, William L Smith, Harry R Munson, Robert F Boswell assigned to A H Robins Company Inc A method of controlling emesis caused by nonplatinum anti-cancer drugs with 2-alkoxy-N-(1azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides having the formula See Patent for Chemical Structure wherein X is oxygen or sulfur; R1 is loweralkyl; and R2 is selected from the group consisting of hydrogen, halo, 4,5benzo, methylsulfonyl, loweralkoxy or Am and n is 1 or 2, and the pharmaceutically acceptable acid addition salts thereof is disclosed.

A process for preparing a medicament adsorbate by sorbing a medicament drug onto a swollen hydrated complex magnesium aluminum silicate and drying the swollen mass to a final solvent content of up to about 20~o by weight of the medicament adsorbate.

4717566 DOSAGE

SYSTEM AND METHOD OF USING SAME

James B Eckenhoff, Richard Cortese, Felix Landrau assigned to ALZA Corporation A dosage form is disclosed for delivering a beneficial agent. The dosage form comprises a wall that surrounds and defines an internal space, a composition comprising a beneficial agent, means in the space for aiding in delivering the compositions from the dosage form and, at least one passageway in the wall for delivering the composition from the dosage form.

4717568 LAMINAR ARRANGEMENT FOR INCREASING DELIVERY OF BENEFICIAL AGENT FROM DISPENSER James B Eckenhoff, Richard Cortese, Felix Landrau assigned to Alza Corporation A laminated arrangement useful for manufacturing a deliver device for delivering a beneficial agent formulation is disclosed. The laminated arrangement comprise first lamina means comprising a beneficial agent formulation in laminar arrangement with a second lamina means exhibiting a lower passage to the beneficial agent then the first lamina means.